|Other Names||Lipoma HMGIC fusion partner-like 1 protein, LHFPL1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13197a was selected from the N-term region of LHFPL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Membrane; Multi-pass membrane protein|
|Tissue Location||Widely expressed. Expressed at high levels in lung, thymus, skeletal muscle, colon and ovary|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene is a member of the lipoma HMGIC fusion partner(LHFP) gene family, which is a subset of the superfamily oftetraspan transmembrane protein encoding genes. Mutations in oneLHFP-like gene result in deafness in humans and mice, and a secondLHFP-like gene is fused to a high-mobility group gene in atranslocation-associated lipoma. Alternatively spliced transcriptvariants have been found, but their biological validity has notbeen determined.
Longo-Guess, C.M., et al. Proc. Natl. Acad. Sci. U.S.A. 102(22):7894-7899(2005)Huang, C., et al. DNA Seq. 15(4):299-302(2004)Petit, M.M., et al. Genomics 57(3):438-441(1999)
If you have any additional inquiries please email technical services at email@example.com.